Literatur:
1. Barakat R.R., Benjamin I., Lewis J.L. jr. et al. Platinum-based chemotherapy for advanced stage of serous ovarian carcinoma of low malignant potnetial. Gynecol Oncol 1995; 59:390-3
2. Beckmann A. M., Sherman K.J., Saran L. et al. Genital-type human papillomavirus infection is not associated with surface epithelial ovarian carcinoma. Gynecol Oncol 1991; 43:247-51
3. Burger C.W., Prinssen H.M., Baak J.P.A., Wagenaar N., Kenemans P. The management of borderline epithelial tumors of the ovary. Int J Gynecol Cancer 2000; 10:181-197
4. Burger C.W. 23. Jahrestagung der Österreichischen Geschellschaft für Reproduktionsmedizin, Innsbruck, September 2007
5. Buy J.N., Ghossain M.A., Sciot C., Bazot M., Guinet C., Prévot S., Hugol D., Laromiguiere M., Truc J.B., Poitout P. et al. Epithelial tumors of the ovary: CT findings and correlation with US. Radiol 1991; 178:811-8
6. Gershenson D.M., Silva E.G. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990; 65:578-85
7. Gershenson D.M., Silva E.G., Tortolero-Luna G. et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer 1998; 83:2157-63
8. Harlow B.L., Weiss N.S., Roth G.J. et al. Case-control study of borderline ovarian tumors: Reproductive history and exposure to exogenous female hormones. Cancer Res 1988; 48:5849-52 9. Harlow B.L., Weiss N.S. A case-control study of borderline ovarian tumors: the influence of perineal exposure to talc. Am J Epidemiol 1989; 130:390-4
10. Lai C.H., Hsueh S., Chang T.C., et al. The role of DNA cytoflowmetry in borderline malignant ovarian tumors. Cancer 1996; 78:794-802
11. Leake J.F., Rader J.S., Woodruff J.D. et al. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991; 42:123-30
12. Lu K.H., Bell D.A., Welch W.R. et al. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res 1998; 58:2328-30
13. Menzin A.W., Rubin S.C., Noumoff J.S. et al. The Accuracy of a Frozen Section Diagnosis of Borderline Ovarian Malignancy. Gynecol Oncol 1995; 59:183-5
14. Nayar R., Siriaunkul S., Robbins K.M. et al. Microinvasion in low malignant potential tumors of the ovary. Hum Pathol 1996; 27:521-7
15. Scully R.E. IGCS-Meeting 2002, Breakfast-Session, October 2002
16. Shushan A., Paltiel O., Gordon L., et al. Ovarian cancer of low malignant potential is not associated with positive familial history. Am J Obstet Gynecol 1996; 175:507-8
17. Siriaunkul S., Robbin K.M., Mc Gowan L. et al. Ovarian mucinous tumors of low malignant potential: A clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol 1995; 14:193
18. Trope C., Kaern J. Management of borderline tumors of the ovary: State of the art. Semin Oncol 1998; 25: 372-80
19. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs; Lyon 2003